Whole study population (n = 365) | Without perfusion defects (n = 238) | |
---|---|---|
Age (years) | 62 ± 9 | 61 ± 9 |
Women | 202 (55 %) | 150 (63 %) |
Body mass index | 25.7 ± 3.5 | 25.4 ± 3.5 |
Current smoker | 47 (13 %) | 31 (13 %) |
Family history of CAD | 142 (39 %) | 89 (37 %) |
ACE-inhibitors | 69 (19 %) | 32 (13 %) |
Beta-blockers | 173 (47 %) | 96 (40 %) |
Statins | 146 (40 %) | 83 (35 %) |
Aspirin | 178 (49 %) | 102 (43 %) |
Systolic blood pressure (mmHg) | 144 ± 23 | 144 ± 22 |
Known CAD | 94 (26 %) | 44 (18 %) |
Previous MI | 51 (14 %) | 19 (8 %) |
Triglycerides (mmol/L) (n = 362) | 1.2 (0.8–1.6) | 1.1 (0.8–1.3) (n = 235) |
Cholesterol (mmol/L) (n = 360) | 5.4 ± 1.3 | 5.4 ± 1.1 (n = 234) |
HDL (mmol/L) | 1.47 (1.24–1.72) | 1.49 (1.29–1.75) |
ApoB/ApoA1 | 0.64 (0.53–0.79) | 0.62 (0.52–0.76) |
Fasting glucose (mmol/L) | 5.3 ± 0.5 | 5.3 ± 0.5 |
Insulin (pmol/L) | 94 (69–125) | 92 (69–122) |
HbA1c (mmol/mol, %) | 36.6 ± 3.8 (5.5 ± 0.3 %) | 36.2 ± 3.5 (5.5 ± 0.32 %) |
HOMA-IR | 3.1 (2.3–4.3) | 3.1 (2.3–4.1) |
RHI (n = 345) | 1.89 (1.55–2.47) | 1.91 (1.59–2.48) (n = 225) |